ARTICLE SUMMARY:
We present selected private financings for May and June, including Alpheus Medical's over-subscribed $50 million Series B round to support its randomized controlled clinical trial on its novel sonodynamic therapy for glioblastoma. Plus a snapshot of our featured cancer impact investor, ACS BrightEdge.
We present selected private financings for May and June and a snapshot of a featured investor, the American Cancer Society’s venture arm, BrightEdge.
